Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page
- Check4 days agoChange DetectedA new revision (v3.6.4) has been added to the Study Record History, replacing the previous revision (v3.6.3). This reflects an updated version of the record.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study record history now shows a new revision entry labeled v3.6.3, indicating the record has been updated to a newer saved version.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision history now shows a new entry for v3.6.2 and removes the v3.6.0 entry, updating the page's version log. This reflects internal version control for the page and does not alter the study data or status.SummaryDifference0.1%

- Check47 days agoChange DetectedThe study page now shows that recruitment is no longer open to participants, clarifying that enrollment has ended. The record history reflects a new revision (v3.6.0) replacing the previous v3.5.5.SummaryDifference0.4%

- Check54 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, replacing the previous revision (v3.5.4), reflecting an update to the page's version history.SummaryDifference0.1%

- Check69 days agoChange DetectedA new history entry (version 9) with a Study Status update was added for 2026-05-19, expanding the record’s current-state information. The entry dated 2025-12-23 was removed from the history.SummaryDifference0.4%

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.